Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review concludes that platelet-rich plasma treatment is effective for androgenetic alopecia, with recommendations for a specific volume, frequency, and duration of therapy for optimal results.

This source explores treatments for male-pattern baldness, highlighting finasteride, which reduces DHT levels to support hair growth, and minoxidil, used for vasodilation and hair health, though the exact mechanisms remain partly unclear.

This study characterized the anatomical and phytochemical features of Viola odorata, which may assist taxonomists in species analysis and improve regulatory processes for quality assurance.

This study concluded that S. hexaphylla extract may improve androgenetic alopecia by reducing 5α-reductase and androgen receptor levels, inhibiting apoptosis, and promoting keratinocyte proliferation in experimental models.

In this study, activated platelet-rich plasma improved hair density and thickness in patients with androgenetic alopecia, with higher platelet counts enhancing these effects over time.

This study found that a double-crosslinked hydrogel using GelMA and sulfhydrylated chitosan showed promising results in healing full-thickness skin wounds in rats by accelerating tissue repair and promoting collagen and blood vessel formation.

This study found that ALRV5XR showed the highest efficacy for terminal hair regrowth in both men and women with androgenetic alopecia, with less treatment resistance compared to other therapies.

This integrative literature review found that oral Minoxidil is a favorable alternative for individuals intolerant to topical application, effectively treating various forms of alopecia, though side effects like increased hair growth and minor dermatological reactions are noted.

This study found that ATP may help reduce ribociclib-induced skin damage in rats by mitigating biochemical changes associated with oxidative stress.

This study suggests that Equisetum debile extracts, particularly the ethyl acetate fraction, may offer natural cosmeceutical benefits for treating hyperpigmentation, delaying skin aging, and remediating hair loss due to androgenic alopecia.

Oral minoxidil may help improve fragile hair.

In this study, researchers developed a new topical atraric acid formulation, AA-TF#15, which showed a significantly higher drug penetration and increased hair regrowth in mice compared to minoxidil and finasteride treatments, suggesting its potential effectiveness for treating scalp androgenic alopecia.

This case report describes a 14-year-old patient with hereditary hypotrichosis simplex who showed significant improvement with combined platelet rich plasma injections and topical minoxidil 2%. The findings suggest that platelet rich plasma could offer new hope for treating this condition.

According to this study, rice bran oil was as effective as 2% minoxidil in improving hair growth parameters, such as VEGF expression, follicle diameter, and hair length, in Wistar rats treated for 21 days, showing potential for preventing hair thinning associated with aging.

This study found that a new oral supplement with sulfurated amino acids and trace elements effectively improved hair growth and reduced hair loss in women with telogen effluvium and mild to moderate androgenetic alopecia.

This study found that platelet-rich plasma treatments improved quality of life for patients with pattern hair loss, as measured by decreased HAIRDEX scores in several domains over 3-5 months.

This review investigates whether combining microneedling with minoxidil is more effective than using minoxidil alone for increasing hair density and diameter in patients with alopecia. Results are not reported.

This review discusses pediatric androgenetic alopecia, emphasizing the diagnostic process and outlining potential treatments, but reports no new clinical results.

This study found that topical valproic acid and 5% minoxidil both significantly increased hair count in patients with female pattern hair loss, suggesting topical valproic acid as a potential treatment option.

This study created new methods to test how well hair care products clean and protect hair from pollution, finding a wide range of effectiveness among different formulas in removing pollutants and preventing their deposit on hair fibers.

This study found that in male patients, a lower right-handed 2D:4D digit ratio combined with older age correlated with increased severity risk of androgenetic alopecia.

This study found that men with early onset androgenetic alopecia often have higher serum uric acid levels and an increased prevalence of hyperuricemia compared to controls.

This study found that topical cetirizine increased hair shaft thickness and improved clinical outcomes from the patients' perspective in female androgenetic alopecia compared to minoxidil alone, with similar side effect profiles.

This study found that combined therapy of low-level light therapy and minoxidil may offer either superior or equivalent hair regrowth compared to minoxidil alone in treating androgenetic alopecia.

This study found that men using 5-alpha-reductase inhibitors showed an increased risk for dementia shortly after starting treatment, which diminished over time, and a consistent association with depression, but no link to suicide.

This letter to the editor reports on an analysis of hair root lipids in female androgenetic alopecia using UPLC-Q-TOF/MS, without presenting new clinical results.

This study developed dissolving microneedles incorporating a new AR degrader for treating androgenetic alopecia, showing that a single application leads to superior hair regeneration compared to daily minoxidil, without systemic toxicity or androgen-related issues.

This study estimated the starting dose range for a finasteride long-acting injectable formulation in humans, suggesting that 16.80 mg may be the optimal starting dose.